Abstract
The clinical benefits of interferon (IFN) β therapy in some multiple sclerosis (MS) patients are still unexplained, raising the question whether polymorphism within the IFNB gene itself would provide an explanation. Screening the IFNB gene by single strand conformation polymorphism (SSCP) analysis and sequencing, a single nucleotide polymorphism was identified. Both alleles were distributed with similar frequencies in MS patients and controls. Significant linkage disequilibrium (LD) between the IFN allele [153C] and allele [02] of the previously analyzed IFNA microsatellite (Epplen et al. Ann Neurol 1997; 41: 341–352) was observed in MS patients only, indicating a disease related haplotype. On the other hand an increased risk (RR = 12.41; Pc < 8 × 10−5) was observed for allele [07]. Hence the study was extended to neighbouring genes. Functionally relevant polymorphisms, ie, premature stop codons in the IFNA10 [Cys20Stop] and IFNA17 [58Stop] genes and an aminoacid (aa) substitution [Ile184Arg] in the IFNA17 gene were analyzed. Patients carrying a non-functional IFNA17 allele bear an increased risk to develop MS (RR = 25.68; Pc < 0.06). in addition, ld analysis between ifna10 [cys20stop], ifna17 [58stop] and the ifna microsatellite alleles provides evidence for ifna14, ifna16 or ifna5 as additional, most likely candidate genes. the present study excludes the ifnb gene as a candidate for ms predisposition but provides first evidence for predisposing ifna genes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Consortia
Additional information
Financial support was provided by the Ruhr-University Bochum (FoRUM project to CH, JTE, DP), the Schering Deutschland GmbH (Berlin, Germany; project to CH) and the Serono Pharma GmbH (Unterschleissheim, Germany; project to CH).
H Przuntek; Department of Neurology, St. Josef Hospital, Ruhr-University, Bochum, Germany; E Sindern, J-P Malin; Department of Neurology, Kliniken Bergmannsheil, Ruhr-University, Bochum, Germany; M Haupts, W Gehlen; Department of Neurology, Knappschaft, Ruhr-University, Bochum, Germany; F Weber, S Poser; Department of Neurology, University Clinic, Göttingen, Germany
Rights and permissions
About this article
Cite this article
Miterski, B., Jaeckel, S., Epplen, J. et al. The interferon gene cluster: a candidate region for MS predisposition?. Genes Immun 1, 37–44 (1999). https://doi.org/10.1038/sj.gene.6363634
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gene.6363634
Keywords
This article is cited by
-
Genetic associations in type I interferon related pathways with autoimmunity
Arthritis Research & Therapy (2010)
-
Variation in the type I interferon gene cluster on 9p21 influences susceptibility to asthma and atopy
Genes & Immunity (2006)
-
Association of a common polymorphism in the promoter of UCP2 with susceptibility to multiple sclerosis
Journal of Molecular Medicine (2005)
-
Multilocus statistics to uncover epistasis and heterogeneity in complex diseases: revisiting a set of multiple sclerosis data
European Journal of Human Genetics (2003)